08:58 AM EDT, 06/27/2025 (MT Newswires) -- Health care stocks were edging higher premarket Friday with the Health Care Select Sector SPDR Fund (XLV) up 0.1% and the iShares Biotechnology ETF (IBB) recently advancing by 0.3%.

Ultragenyx Pharmaceutical ( RARE ) shares were up 4% after the company said the US Food and Drug Administration granted breakthrough therapy designation to GTX-102 as a treatment for Angelman syndrome.